Blog

For the quarter ended September 2025, Premier, Inc. (PINC) reported revenue of $240 million, down 3.3% over the same period last year. EPS came in at $0.30, compared to $0.34 in the year-ago

Palantir Technologies Inc. (PLTR) reported $1.18 billion in revenue for the quarter ended September 2025, representing a year-over-year increase of 62.8%. EPS of $0.21 for the same period compares

Financial services technology solutions provider Fidelity National Information Services, Inc. FIS is set to report third-quarter 2025 results on Nov. 5, 2025, before the opening bell. The Zacks

Axsome Therapeutics AXSM incurred a loss of 94 cents per share in the third quarter of 2025, wider than the Zacks Consensus Estimate of a loss of 82 cents. The company had incurred a loss of $1.34

TG Therapeutics TGTX reported earnings of $2.43 per share for the third quarter of 2025, which significantly beat the Zacks Consensus Estimate of 24 cents. The company had reported earnings of 2

The electronics stocks market's quarterly releases are expected to reflect the continued expansion of artificial intelligence infrastructure and data centre buildouts globally. Accelerated

Tango Therapeutics, Inc. (TNGX) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to a loss of $0.27 per share a year ago

CDW Corporation (CDW) reported third-quarter 2025 non-GAAP earnings per share (EPS) of $2.71, surpassing the Zacks Consensus Estimate of $2.53. Also, the bottom line increased 3% year over year.

The

Premier, Inc. (PINC) came out with quarterly earnings of $0.3 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.34 per share a year ago. These

The market expects Viridian Therapeutics, Inc. (VRDN) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This

The market expects Sky Harbour Group Corporation (SKYH) to deliver flat earnings compared to the year-ago quarter on higher revenues when it reports results for the quarter ended September 2025

Wall Street expects flat earnings compared to the year-ago quarter on higher revenues when SKYX Platforms Corp. (SKYX) reports results for the quarter ended September 2025. While this widely-known

The market expects Plug Power (PLUG) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus

The market expects Ondas Holdings Inc. (ONDS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2025. This widely-known

Orchestra BioMed Holdings, Inc. (OBIO) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known

Wall Street expects a year-over-year increase in earnings on higher revenues when Ovid Therapeutics (OVID) reports results for the quarter ended September 2025. While this widely-known consensus

Bolt Biotherapeutics, Inc. (BOLT) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known

Wall Street expects a year-over-year increase in earnings on higher revenues when HIVE Digital Technologies (HIVE) reports results for the quarter ended September 2025. While this widely-known

For the quarter ended September 2025, NNN REIT (NNN) reported revenue of $229.77 million, up 5.3% over the same period last year. EPS came in at $0.86, compared to $0.53 in the year-ago quarter.

The

Fate Therapeutics (FATE) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known consensus

For the quarter ended September 2025, Pfizer (PFE) reported revenue of $16.65 billion, down 5.9% over the same period last year. EPS came in at $0.87, compared to $1.06 in the year-ago quarter.

The

For the quarter ended September 2025, Hamilton Lane (HLNE) reported revenue of $190.88 million, up 27.3% over the same period last year. EPS came in at $1.54, compared to $1.07 in the year-ago

The market expects Opus Genetics, Inc. (IRD) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended September 2025. This widely-known

For the quarter ended September 2025, Marriott International (MAR) reported revenue of $6.49 billion, up 3.7% over the same period last year. EPS came in at $2.47, compared to $2.26 in the year-ago

Hertz Global Holdings, Inc. (HTZ) reported $2.48 billion in revenue for the quarter ended September 2025, representing a year-over-year decline of 3.8%. EPS of $0.12 for the same period compares to